CAPPELLO JOSEPH (VP, Pharmaceutical Development) received a stock award from GENELUX CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/18/2026ACC: 0001493152-26-029419
Officer· VP, Pharmaceutical Development
Since Jan 2023
+174.84K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
174.84K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+174.84K
Price / share
—
Trade value
—
% of position
113.1%
6/16/2026
154.55K→329.39K
Total
Net shares
+174.84K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/16/2026 | A · Award | +174.84K | — | — | 113.1% | 154.55K | 329.39K |
| Total | +174.84K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported